Inventor · disambiguated record
Matthew B. Boxer
Also filed as: BOXER MATTHEW · BOXER MATTHEW B · BOXER MATTHEW BRIAN
14 granted patents·8 pending applications·48 citations·filing 2009–2022
88Inventor score
Files withUS HEALTH5BELLBROOK LABS LLC3BETH ISRAEL DEACONESS MEDICAL CT INC3BOXER MATTHEW B2THOMAS CRAIG J2
Top patents by PatentIndex Score
22 records- 0195US9708267B2Activators of human pyruvate kinaseUS HEALTH·Filed 2015·Granted Jul 18, 2017·16 cites·20 claims
- 0292US8841305B2Activators of the human pyruvate kinase M2 receptorTHOMAS CRAIG J·Filed 2009·Granted Sep 23, 2014·24 cites·26 claims
- 0374US10413548B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Sep 17, 2019·1 cites·3 claims
- 0472US9447087B2Galactokinase inhibitors for the treatment and prevention of associated diseases and disordersBOXER MATTHEW B·Filed 2011·Granted Sep 20, 2016·4 cites·13 claims
- 0570US9730941B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Aug 15, 2017·1 cites·3 claims
- 0667US9365612B2Caspase inhibitorsTHOMAS CRAIG·Filed 2011·Granted Jun 14, 2016·2 cites·16 claims
- 0763US9290512B2Activators of human pyruvate kinaseUS HEALTH·Filed 2014·Granted Mar 22, 2016·0 cites·13 claims
- 0862US11129835B2Methods and compositions for the inhibition of PIN1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Sep 28, 2021·0 cites·4 claims
- 0958US9707230B2Activators of human pyruvate kinaseUS HEALTH·Filed 2016·Granted Jul 18, 2017·0 cites·21 claims
- 1058US8937067B2Activators of human pyruvate kinaseTHOMAS CRAIG J·Filed 2012·Granted Jan 20, 2015·0 cites·12 claims
- 1158US2025066345A1Compositions and methods of use to treat 12-lipoxygenase (12-lox) mediated diseasesVERALOX THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1257US2025057857A1Aqueous parenteral pharmaceutical formulations containing 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivativesVERALOX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1355US10471061B2Galactokinase inhibitors for the treatment and prevention of associated diseases and disordersUS HEALTH·Filed 2018·Granted Nov 12, 2019·0 cites·20 claims
- 1452US2024174684A1INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSBELLBROOK LABS LLC·Filed 2022·Application pending·0 cites
- 1546US10836759B2Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancerUS HEALTH·Filed 2017·Granted Nov 17, 2020·0 cites·20 claims
- 1645US2017035760A1Galactokinase inhibitors for the treatment and prevention of associated diseases and disordersTHE US OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2016·Application pending·0 cites
- 1742US2022073532A1Inhibitors of cgas activity as therapeutic agentsBELLBROOK LABS LLC·Filed 2020·Application pending·0 cites
- 1842US2022073470A1Inhibitors of cgas activity as therapeutic agentsBELLBROOK LABS LLC·Filed 2020·Application pending·0 cites
- 1940US2013109672A1Activators of human pyruvate kinaseBOXER MATTHEW B·Filed 2011·Application pending·0 cites
- 2040US2016046616A1Nrf2 small molecule inhibitors for cancer therapyUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2132US11225469B2Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2016·Granted Jan 18, 2022·0 cites·25 claims
- 2231US10703746B2Mutant IDH1 inhibitors useful for treating cancerTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2015·Granted Jul 7, 2020·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Matthew B. Boxer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →